# Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

> **NCT02053909** · PHASE4 · COMPLETED · sponsor: **Boca Raton Regional Hospital** · enrollment: 250 (actual)

## Conditions studied

- Saphenous Vein Graft Disease

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02053909
- **Lead sponsor:** Boca Raton Regional Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2020-08
- **Final completion:** 2021-08
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02053909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02053909, "Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02053909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*